Factors Associated With Mortality in Streptococcal Anginosus Bacteremia
ConditionStreptococcal Infections
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Strasbourg, France
About this trial
Streptococcal anginosus infections (S. constellatus, S. anginosus, and S. intermedius) are characterized by their severity, linked to high mortality and frequent infectious complications. Several studies in the literature highlight this severity, with mortality rates estimated at around 15%.
The aim of this research is to identify the factors associated with mortality in Streptococcal anginosus bacteremia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Major subject (≥18 years old)
Hospitalized between January 1, 2019, and December 31, 2024, in one of the participating centers
Having presented during the study period at least one positive blood culture for Streptococcus anginosus, Streptococcus constellatus, or Streptococcus intermedius in a laboratory at a participating center
Disqualifiers
Refusal to participate in the study
Trial population
Major subject having presented during the study period at least one positive blood culture for Streptococcus anginosus, Streptococcus constellatus, or Streptococcus intermedius in a laboratory at a participating center
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
28-day in-hospital mortality
28-Day In-Hospital Mortality Following Streptococcal Infection
Time frame
28-Day Mortality Following Streptococcal InfectionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov